HUMAN MONOCLONAL ANTIBODY AND DRUG FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS DISEASES COMPRISING SAME AS EFFECTIVE INGREDIENT

A human monoclonal antibody which reacts with several O antigens of Pseudomonas aeruginosa (esp. with O antigens of type A+F, D+I, E+F, or G+H) is obtd. by culture of a suitable antibody-producing cell line which may be either a virus-transformed cell line (e.g. Epstein-Barr virus-transformed) or a...

Full description

Saved in:
Bibliographic Details
Main Authors FUKUDA, TAMOTSU, ONO, YASUSHI, SHIGETA, SHIRO, KUROIWA, YASUYUKI, OOKA, HISAYOSHI
Format Patent
LanguageEnglish
French
German
Published 16.03.1989
Edition4
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:A human monoclonal antibody which reacts with several O antigens of Pseudomonas aeruginosa (esp. with O antigens of type A+F, D+I, E+F, or G+H) is obtd. by culture of a suitable antibody-producing cell line which may be either a virus-transformed cell line (e.g. Epstein-Barr virus-transformed) or a hybridoma derived from human or animal cells, and esp. from normal lymph cells. The antibody is obtd. by culture of one of the following cell lines: MP-5082 (FERM P9745); MP-4095 (FERM-P 9750); MP-5064 (FERM-P 9751); MP-5075 (FERM-P 9752); MP-5104 (FERM-P 9753); MP -5038 (FERM-BP 1596); MP-5035 (FERM-BP 1598) or MP-5046 (FERM -BP 1599).
Bibliography:Application Number: EP19880900105